Section Arrow
Quote
PTHL.NASDAQ
- Pheton Holdings Ltd
Quotes are at least 15-min delayed:2025/10/23 16:14 EDT
After Hours
Last
 0.6217
0 (0.00%)
Bid
0.6113
Ask
0.6217
High 0.6217 
Low 0.6217 
Volume 1001 
Regular Hours
Last
 0.6217
+0.0107 (+1.75%)
Day High 
0.64999 
Prev. Close
0.611 
1-M High
0.8995 
Volume 
30.23K 
Bid
0.6113
Ask
0.6217
Day Low
0.6 
Open
0.6 
1-M Low
0.5506 
Market Cap 
8.71M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.66 
20-SMA 0.71 
50-SMA 0.76 
52-W High 32 
52-W Low 0.505 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.05/--
Enterprise Value
8.71M
Balance Sheet
Book Value Per Share
0.43
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
448.20K
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ITGRInteger Holdings Corp73.89-35.22-32.28%46.63PE
After Hours 73.6901 -0.1999 -0.27%
QSIQuantum-Si2.2--0.000%-- 
After Hours 2.21 +0.01 +0.45%
BSXBoston Scientific Corp102.39-1.46-1.41%62.08PE
After Hours 104.32 +1.93 +1.88%
PACBPacific Biosciences of California1.95+0.11+5.98%-- 
After Hours 1.95 0 0.00%
MDTMedtronic plc94.21-1.69-1.76%26.49PE
After Hours 94.21 0 0.00%
Quotes are at least 15-min delayed：2025/10/23 16:14 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy.FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.